(Q28219159)

English

Endoscopic ulcer rates in healthy subjects associated with use of aspirin (81 mg q.d.) alone or coadministered with celecoxib or naproxen: a randomized, 1-week trial

scientific article (publication date: March 2008)

In more languages

Statements

scholarly article

0 references

Endoscopic ulcer rates in healthy subjects associated with use of aspirin (81 mg q.d.) alone or coadministered with celecoxib or naproxen: a randomized, 1-week trial (English)

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Jay L Goldstein

1

0 references

James Aisenberg

2

0 references

Salam F Zakko

3

0 references

Manuela F Berger

4

0 references

William E Dodge

5

0 references

language of work or name

0 references

publication date

March 2008

0 references

Digestive Diseases and Sciences

0 references

53

0 references

3

0 references

647-56

0 references

Prophylactic aspirin and risk of peptic ulcer bleeding

1 reference

https://api.crossref.org/works/10.1007%2FS10620-007-9903-4

21 January 2018

Disruption of hedgehog signaling reveals a novel role in intestinal morphogenesis and intestinal-specific lipid metabolism in mice

1 reference

https://api.crossref.org/works/10.1007%2FS10620-007-9903-4

21 January 2018

Adverse effects of cyclooxygenase 2 inhibitors on renal and arrhythmia events: meta-analysis of randomized trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/17676393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primer: managing NSAID-induced ulcer complications--balancing gastrointestinal and cardiovascular risks

1 reference

https://pubmed.ncbi.nlm.nih.gov/17676393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17676393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The impact of low-dose aspirin on endoscopic gastric and duodenal ulcer rates in users of a non-selective non-steroidal anti-inflammatory drug or a cyclo-oxygenase-2-selective inhibitor

1 reference

https://pubmed.ncbi.nlm.nih.gov/17676393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced incidence of gastroduodenal ulcers with celecoxib, a novel cyclooxygenase-2 inhibitor, compared to naproxen in patients with arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17676393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17676393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

COX-2 inhibitor use after Vioxx: careful balance or end of the rope?

1 reference

https://pubmed.ncbi.nlm.nih.gov/17676393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Over-the-counter pain reliever and aspirin use within a sample of long-term cyclooxygenase 2 users

1 reference

https://pubmed.ncbi.nlm.nih.gov/17676393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/17676393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of very low dose daily, long-term aspirin therapy on gastric, duodenal, and rectal prostaglandin levels and on mucosal injury in healthy humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/17676393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/17676393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tolerability and adverse events in clinical trials of celecoxib in osteoarthritis and rheumatoid arthritis: systematic review and meta-analysis of information from company clinical trial reports

1 reference

https://pubmed.ncbi.nlm.nih.gov/17676393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations

1 reference

https://pubmed.ncbi.nlm.nih.gov/17676393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison

1 reference

https://pubmed.ncbi.nlm.nih.gov/17676393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17676393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ulcer formation with low-dose enteric-coated aspirin and the effect of COX-2 selective inhibition: a double-blind trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17676393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17676393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17676393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17676393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 Update

1 reference

https://pubmed.ncbi.nlm.nih.gov/17676393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gastrointestinal complications of over-the-counter nonsteroidal antiinflammatory drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/17676393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17676393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low-dose aspirin for the prevention of atherothrombosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17676393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention

1 reference

https://pubmed.ncbi.nlm.nih.gov/17676393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of first- and second-generation cyclooxygenase-2-selective nonsteroidal antiinflammatory drugs and risk of acute myocardial infarction.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17676393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/17676393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17676393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10620-007-9903-4

0 references

Dimensions Publication ID

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28219159&oldid=2177520075"